1.
Hammel P,
Huguet F,
van Laethem J,
Goldstein D,
Glimelius B,
Artru P et al.
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib.
JAMA.
2016;315(17):1844.
2.
Loehrer P,
Feng Y,
Cardenes H,
Wagner L,
Brell J,
Cella D et al.
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial.
Journal of Clinical Oncology.
2011;29(31):4105-4112.
3.
Chauffert B,
Mornex F,
Bonnetain F,
Rougier P,
Mariette C,
Bouche O et al.
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy,
infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer.
Definitive results of the 2000-01 FFCD/SFRO study.
Annals of Oncology.
2008;19(9):1592-1599.
4.
Treatment of Locally Unresectable Carcinoma of the Pancreas: Comparison of Combined-Modality Therapy (Chemotheraphy Plus Radiotherapy) to Chemotheraphy Alone.
JNCI Journal of the National Cancer Institute.
1988;80(10):751-755.
5.
Klaassen D,
MacIntyre J,
Catton G,
Engstrom P,
Moertel C.
Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.
Journal of Clinical Oncology.
1985;3(3):373-378.
6.
Huang W,
Kuo Y,
Tsang N,
Hsu H,
Shen W,
Chou W et al.
Concurrent Chemoradiotherapy with or without Induction Chemotherapy versus Chemotherapy Alone in Patients with Locally Advanced Pancreatic Cancer.
Anticancer Research.
2014;34:6755-6762.
7.
Wang B,
Cao W,
Yu J,
Wang X.
Gemcitabine-based Concurrent Chemoradiotherapy Versus Chemotherapy Alone in Patients with Locally Advanced Pancreatic Cancer.
Asian Pacific Journal of Cancer Prevention.
2012;13(5):2129-2132.
8.
Huguet F,
André T,
Hammel P,
Artru P,
Balosso J,
Selle F et al.
Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies.
Journal of Clinical Oncology.
2007;25(3):326-331.